Impossible to say. Novartis was already in that space. All they have done is buy a competitor.
I am not aware of any big pharma working in the OPMD space. I think we have no competition, which is both a pro and a con. If get through our trial successfully, I can see interest heating up but that is some way off.
- Forums
- ASX - By Stock
- BLT
- Is BLT next?
Is BLT next?, page-5
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)